Bridging Over Troubled Waters-How the United States 2018 Heart Allocation System Altered Transplant Bridging

Les James1, Deane E Smith1

  • 1Department of Cardiothoracic Surgery, NYU Langone Health, New York, NY 10010, USA.

Insights

The 2018 heart transplant allocation system impacts waitlist mortality and outcomes. Bridging strategies like mechanical circulatory support (MCS) are evolving with this system.

Area of Science:

  • Cardiology
  • Transplant Surgery
  • Medical Systems Analysis

Background:

  • The 2018 US heart allocation system revision aimed to improve equity and outcomes.
  • Significant advancements in mechanical circulatory support (MCS) have occurred concurrently.
  • Bridging strategies are crucial for managing patients awaiting heart transplantation.

Purpose of the Study:

  • To review the history and revisions of the US heart allocation system.
  • To analyze initial outcomes post-implementation, focusing on waitlist mortality and post-transplant results.
  • To examine evolving bridging strategies using VA ECMO, IABP, and LVADs.

Main Methods:

  • Historical review of the heart allocation system.
  • Analysis of initial outcomes data following the 2018 system implementation.
  • Review of current bridging strategies in heart transplantation.

Main Results:

  • The 2018 system has shown initial impacts on waitlist dynamics and transplant outcomes.
  • Evolving MCS technologies are increasingly utilized for bridging patients.
  • Specific bridging strategies demonstrate varied effects on patient survival and recovery.

Conclusions:

  • The 2018 heart allocation system necessitates ongoing evaluation.
  • Optimizing bridging strategies with MCS is critical for successful heart transplantation.
  • Further research is needed to refine allocation and support protocols.

Related Concept Videos

Bone Marrow Sampling and Transplants01:22

Bone Marrow Sampling and Transplants

Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy the...
Tissue Transplantation01:24

Tissue Transplantation

Tissue transplantation is a significant medical procedure involving the transfer of cells, tissues, or organs from a donor to a recipient, with the primary aim of restoring lost functions. This procedure is crucial in treating a broad spectrum of diseases, including kidney diseases, liver failure, heart disease, and certain types of cancers.
The Biology of Tissue Transplantation
The biology of tissue transplantation hinges on the Major Histocompatibility Complex (MHC) molecules. These molecules...
Kidney Transplant I: Introduction01:28

Kidney Transplant I: Introduction

A kidney transplant is a surgical approach that involves replacing a non-functioning kidney with a healthy one from a donor. This procedure is often a treatment option for end-stage renal disease (ESRD) patients. The method requires careful recipient selection, including evaluating various medical and psychosocial factors. These criteria vary between transplant centers but generally include assessments of the patient's overall health, adherence to medical recommendations, and lifestyle...